ES2098403T3 - Derivados de la imidazoindolizina y procedimiento para su preparacion. - Google Patents

Derivados de la imidazoindolizina y procedimiento para su preparacion.

Info

Publication number
ES2098403T3
ES2098403T3 ES92114987T ES92114987T ES2098403T3 ES 2098403 T3 ES2098403 T3 ES 2098403T3 ES 92114987 T ES92114987 T ES 92114987T ES 92114987 T ES92114987 T ES 92114987T ES 2098403 T3 ES2098403 T3 ES 2098403T3
Authority
ES
Spain
Prior art keywords
derivatives
preparation
imidazoindolizin
procedure
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92114987T
Other languages
English (en)
Inventor
Yasushi Honma
Yasuo Sekine
Sumihiro Nomura
Kazuaki Naito
Hiroshi Narita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2098403T3 publication Critical patent/ES2098403T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

UN DERIVADO DE LA IMIDAZOINDOLICINA CON LA FORMULA [I]: EN DONDE R1 ES ALQUILO INFERIOR, R2 ES HIDROGENO, CIANO, ALQUIL INFERIOR, ALCANOILO INFERIOR, ALCOXICARBONILO INFERIOR, FENIL ALCOXICARBONILO INFERIOR, ALQUILSULFONILO INFERIOR, FENILO SUBSTITUIDO O NO SUBSTITUIDO, ARILCARBONILO, CARBONILO SUBSTITUIDO POR UN GRUPO HETEROMONOCICLICO QUE CONTIENE NITROGENO CON 5O 6 UIDO Y M ES 0 O 1, O SU SAL FARMACEUTICAMENTE ACEPTABLE Y UN PROCESO PARA SU PREPARACION, DICHOS DERIVADOS DE LA IMIDAZOINDOLICINA Y SUS SALES FARMACEUTICAMENTE ACEPTABLES MUESTRAN EXCELENTES ACTIVIDADES INHIBITORIAS DE LA ANGIOTENSINA II Y SON UTILES EN LA PROFILAXIS Y EL TRATAMIENTO DE LA HIPERTENSION.
ES92114987T 1991-09-10 1992-09-02 Derivados de la imidazoindolizina y procedimiento para su preparacion. Expired - Lifetime ES2098403T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30856091 1991-09-10
JP5304492 1992-01-27

Publications (1)

Publication Number Publication Date
ES2098403T3 true ES2098403T3 (es) 1997-05-01

Family

ID=26393753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92114987T Expired - Lifetime ES2098403T3 (es) 1991-09-10 1992-09-02 Derivados de la imidazoindolizina y procedimiento para su preparacion.

Country Status (16)

Country Link
US (1) US5268377A (es)
EP (1) EP0531876B1 (es)
JP (1) JP2590797B2 (es)
KR (1) KR0168457B1 (es)
AT (1) ATE146474T1 (es)
AU (1) AU644539B2 (es)
CA (1) CA2077420C (es)
DE (1) DE69216013T2 (es)
DK (1) DK0531876T3 (es)
ES (1) ES2098403T3 (es)
FI (1) FI98369C (es)
GR (1) GR3022106T3 (es)
ID (1) ID902B (es)
IL (1) IL103021A (es)
MY (1) MY129927A (es)
SG (1) SG42962A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271576A (ja) * 1993-03-19 1994-09-27 Upjohn Co:The イミダゾール誘導体の製法
FR2712592B1 (fr) * 1993-11-17 1995-12-22 Adir Nouveaux dérivés tricycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
WO2018005591A1 (en) 2016-06-29 2018-01-04 Universite De Montreal Biarylmethyl heterocycles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1047148A1 (ru) * 1981-03-30 1986-12-23 Институт физико-органической химии и углехимии АН УССР Бензилиденпроизводные имидазо-[4,5-L]-индолизинов,обладающие бактериостатической и фунгистатической активностью
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
US4816463A (en) * 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
IL103021A (en) 1996-10-16
IL103021A0 (en) 1993-02-21
EP0531876B1 (en) 1996-12-18
DE69216013D1 (de) 1997-01-30
FI924043A0 (fi) 1992-09-10
FI98369C (fi) 1997-06-10
KR0168457B1 (ko) 1999-01-15
AU2205692A (en) 1993-03-11
FI98369B (fi) 1997-02-28
GR3022106T3 (en) 1997-03-31
AU644539B2 (en) 1993-12-09
SG42962A1 (en) 1997-10-17
EP0531876A3 (en) 1993-05-05
EP0531876A2 (en) 1993-03-17
CA2077420C (en) 1998-08-25
FI924043L (fi) 1993-03-11
JP2590797B2 (ja) 1997-03-12
ID902B (id) 1996-09-09
CA2077420A1 (en) 1993-03-11
KR930006024A (ko) 1993-04-20
ATE146474T1 (de) 1997-01-15
JPH05279365A (ja) 1993-10-26
DE69216013T2 (de) 1997-05-07
MY129927A (en) 2007-05-31
DK0531876T3 (es) 1997-02-17
US5268377A (en) 1993-12-07

Similar Documents

Publication Publication Date Title
ES2183905T3 (es) Inhibidores de metaloproteasa de matriz.
UA8022A1 (uk) Спосіб одержання похідних бензімідазолу у вигляді суміші ізомерів або індивідуальних ізомерів у вільному вигляді або у вигляді їх фізіологічно прийнятих солей
TW197435B (es)
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ES2143526T3 (es) Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos.
DK0637299T3 (da) 20-methylsubstituerede vitamin D-derivater
DK0491664T3 (da) Indolderivater som serotonin-antagonister
ES2090855T3 (es) Derivados de naftaleno, procedimientos para su preparacion y productos intermediarios apropiados.
SE9103572D0 (sv) Organic salts of n,n'-diacetyl cystine
NZ230973A (en) Process for the preparation of 7-substituted, hept-6-enoic and heptanoic acids and selected derivatives and optical isomers
EP0990650A4 (en) TRICYCLIC PYRENE OR PYRAZOLE DERIVATIVES
CO4410329A1 (es) Nuevos pirrolocarbazoles
PE25998A1 (es) DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
LU90732I2 (en) Synercid
IT1230595B (it) Perossiacidi immido derivati
AR034088A1 (es) Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento
ES2133013T3 (es) Complejos de cromo 1:2, su produccion y uso.
ES2195313T3 (es) Derivados de imino-aza-antraciclinona para el tratamiento de la amiloidosis.
ES2109962T3 (es) Derivados de la naftiridina condensados.
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
PT92175A (pt) Processo para a preparacao de 3-amino-sidnoniminas substituidas e de produtos intermediarios farmacologicamente activos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 531876

Country of ref document: ES